These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 37469559)

  • 1. Protein structural insights into a rare PCSK9 gain-of-function variant (R496W) causing familial hypercholesterolemia in a Saudi family: whole exome sequencing and computational analysis.
    Shaik NA; Al-Shehri N; Athar M; Awan A; Khalili M; Al Mahadi HB; Hejazy G; Saadah OI; Al-Harthi SE; Elango R; Banaganapalli B; Alefishat E; Awan Z
    Front Physiol; 2023; 14():1204018. PubMed ID: 37469559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and functional characterization of two rare LDLR stop gain variants (p.C231* and p.R744*) in Saudi familial hypercholesterolemia patients.
    Awan Z; Batran A; Al-Allaf FA; Alharbi RS; Hegazy GA; Jamalalail B; Almansouri M; Bima AI; Almukadi H; Kutbi HI; Altayar AE; Banaganapalli B; Shaik NA
    Panminerva Med; 2023 Dec; 65(4):479-490. PubMed ID: 35274909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel LDLR Variant in Familial Hypercholesterolemia: NGS-Based Identification, In Silico Characterization, and Pharmacogenetic Insights.
    Athar M; Toonsi M; Abduljaleel Z; Bouazzaoui A; Bogari NM; Dannoun A; Al-Allaf FA
    Life (Basel); 2023 Jul; 13(7):. PubMed ID: 37511917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The LDLR c.501C>A is a disease-causing variant in familial hypercholesterolemia.
    Hu H; Chen R; Hu Y; Wang J; Lin S; Chen X
    Lipids Health Dis; 2021 Sep; 20(1):101. PubMed ID: 34511120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compound heterozygous LDLR variant in severely affected familial hypercholesterolemia patient.
    Al-Allaf FA; Alashwal A; Abduljaleel Z; Taher MM; Bouazzaoui A; Abalkhail H; Al-Allaf AF; Athar M
    Acta Biochim Pol; 2017; 64(1):75-79. PubMed ID: 27878139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of New Copy Number Variation and the Evaluation of a CNV Detection Tool for NGS Panel Data in Polish Familial Hypercholesterolemia Patients.
    Rutkowska L; Pinkier I; Sałacińska K; Kępczyński Ł; Salachna D; Lewek J; Banach M; Matusik P; Starostecka E; Lewiński A; Płoski R; Stawiński P; Gach A
    Genes (Basel); 2022 Aug; 13(8):. PubMed ID: 36011335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PCSK 9 gain-of-function mutations (R496W and D374Y) and clinical cardiovascular characteristics in a cohort of Turkish patients with familial hypercholesterolemia.
    Kaya E; Kayıkçıoğlu M; Tetik Vardarlı A; Eroğlu Z; Payzın S; Can L
    Anatol J Cardiol; 2017 Oct; 18(4):266-272. PubMed ID: 28777095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis of clinical phenotypes and variants of LDLR gene in two Chinese patients with familial hypercholesterolemia].
    Wang K; Sun T; Zhang X; Zhang Y; Gao H; Ren Y; Li X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2022 Dec; 39(12):1344-1348. PubMed ID: 36453956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Saudi Familial Hypercholesterolemia Patients With Rare
    Awan ZA; Rashidi OM; Al-Shehri BA; Jamil K; Elango R; Al-Aama JY; Hegele RA; Banaganapalli B; Shaik NA
    Front Med (Lausanne); 2021; 8():694668. PubMed ID: 34249980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of pathogenic variants in the Brazilian cohort with Familial hypercholesterolemia using exon-targeted gene sequencing.
    Borges JB; Oliveira VF; Dagli-Hernandez C; Ferreira GM; Barbosa TKAA; da Silva Rodrigues Marçal E; Los B; Malaquias VB; Bortolin RH; Freitas RCC; Mori AA; Bastos GM; Gonçalves RM; Araújo DB; Zatz H; Bertolami A; Faludi AA; Bertolami MC; de Moraes Rego Souza AG; França JÍD; Thurow HS; Hirata TDC; Nakaya HTI; Jannes CE; da Costa Pereira A; Silbiger VN; Luchessi AD; Araújo JNG; Nakazone MA; Carmo TS; Souza DRS; Moriel P; Wang JYT; Naslavsky MS; Gorjão R; Pithon-Curi TC; Curi R; Fajardo CM; Wang HL; Garófalo AR; Cerda A; Sampaio MF; Hirata RDC; Hirata MH
    Gene; 2023 Jul; 875():147501. PubMed ID: 37217153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Deep Intronic Variant in LDLR in Familial Hypercholesterolemia.
    Reeskamp LF; Hartgers ML; Peter J; Dallinga-Thie GM; Zuurbier L; Defesche JC; Grefhorst A; Hovingh GK
    Circ Genom Precis Med; 2018 Dec; 11(12):e002385. PubMed ID: 30562117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The benign c.344G > A: p.(Arg115His) variant in the LDLR gene interpreted from a pedigree-based genetic analysis of familial hypercholesterolemia.
    Hori M; Takahashi A; Son C; Ogura M; Harada-Shiba M
    Lipids Health Dis; 2020 Apr; 19(1):62. PubMed ID: 32252761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of New Genetic Determinants in Pediatric Patients with Familial Hypercholesterolemia Using a Custom NGS Panel.
    Rutkowska L; Sałacińska K; Salachna D; Matusik P; Pinkier I; Kępczyński Ł; Piotrowicz M; Starostecka E; Lewiński A; Gach A
    Genes (Basel); 2022 Jun; 13(6):. PubMed ID: 35741760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ABCG5 and ABCG8 genetic variants in familial hypercholesterolemia.
    Reeskamp LF; Volta A; Zuurbier L; Defesche JC; Hovingh GK; Grefhorst A
    J Clin Lipidol; 2020; 14(2):207-217.e7. PubMed ID: 32088153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Novel and Known LDLR Variants Triggering Severe Familial Hypercholesterolemia in Saudi Families.
    Alnouri F; Al-Allaf FA; Athar M; Al-Rasadi K; Alammari D; Alanazi M; Abduljaleel Z; Awan Z; Bouazzaoui A; Dairi G; Elbjeirami WM; Karra H; Kinsara AJ; Taher MM
    Curr Vasc Pharmacol; 2022; 20(4):361-369. PubMed ID: 35249492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of LDLR and PCSK9 pathogenic variants in Japanese heterozygous familial hypercholesterolemia patients.
    Hori M; Ohta N; Takahashi A; Masuda H; Isoda R; Yamamoto S; Son C; Ogura M; Hosoda K; Miyamoto Y; Harada-Shiba M
    Atherosclerosis; 2019 Oct; 289():101-108. PubMed ID: 31491741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel PCSK9 (Proprotein Convertase Subtilisin Kexin Type 9) Variants in Patients With Familial Hypercholesterolemia From Cape Town.
    Huijgen R; Blom DJ; Hartgers ML; Chemello K; Benito-Vicente A; Uribe KB; Behardien Z; Blackhurst DM; Brice BC; Defesche JC; de Jong AG; Jooste RJ; Solomon GAE; Wolmarans KH; Hovingh GK; Martin C; Lambert G; Marais AD
    Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):934-943. PubMed ID: 33147992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole-Exomes Sequencing Delineates Gene Variants Profile in a Young Saudi Male with Familial Hypercholesterolemia: Case Report.
    Nuglozeh E
    J Clin Diagn Res; 2017 Jun; 11(6):GD01-GD06. PubMed ID: 28764195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of publicly available LDLR, APOB, and PCSK9 variants associated with familial hypercholesterolemia: application of ACMG guidelines and implications for familial hypercholesterolemia diagnosis.
    Chora JR; Medeiros AM; Alves AC; Bourbon M
    Genet Med; 2018 Jun; 20(6):591-598. PubMed ID: 29261184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of Definite Diagnosis of Familial Hypercholesterolemia Using an Expanding Genetic Analysis.
    Cao YX; Sun D; Liu HH; Jin JL; Li S; Guo YL; Wu NQ; Zhu CG; Liu G; Dong Q; Sun J; Chen XH; Li JJ
    JACC Asia; 2021 Jun; 1(1):82-89. PubMed ID: 36338372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.